The success of Sildenafil initially sparked a surge for major pharmaceutical companies, however recent changes present a uncertain scenario for investors. Generic alternatives are eroding revenue, and persistent legal https://leaayuu605510.ziblogs.com/41488385/viagra-and-pharma-a-volatile-bet